FITC Anti-Human CD39 Antibody[A1]

FITC Anti-Human CD39 Antibody[A1]

The FITC Anti-Human CD39 Antibody [A1] is a highly specific and reliable tool designed for the detection and analysis of CD39 expression in human samples. CD39, also known as ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1), is a cell surface protein that plays a crucial role in regulating immune responses and maintaining tissue homeostasis. This antibody is conjugated with FITC (fluorescein isothiocyanate), a bright and photostable fluorochrome, enabling direct visualization and quantification of CD39 expression by flow cytometry or fluorescence microscopy.

This antibody has been extensively validated and optimized to ensure exceptional performance and reproducibility. It exhibits high specificity towards human CD39, with minimal cross-reactivity to other antigens, ensuring accurate and reliable results. The FITC conjugation provides excellent sensitivity, allowing for the detection of low levels of CD39 expression, even in samples with limited cell numbers.

The FITC Anti-Human CD39 Antibody [A1] is suitable for a wide range of applications, including immunophenotyping, functional studies, and biomarker discovery. It can be used with various human sample types, such as peripheral blood mononuclear cells (PBMCs), whole blood, and tissue sections. With its exceptional performance, this antibody enables researchers to gain valuable insights into the role of CD39 in immune regulation and its potential as a therapeutic target in various diseases, including cancer, autoimmune disorders, and inflammatory conditions.